Trevi Therapeutics (TRVI) Share-based Compensation (2018 - 2026)
Trevi Therapeutics' Share-based Compensation was $3.27 million in Q2 2026, up 136.4% from $1.38 million a year earlier and up 49.3% from the prior quarter.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Share-based Compensation (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Trevi Therapeutics' Share-based Compensation was $8.06 million through Jun 30, 2026, up 86.0% year-over-year; for FY2025, it came in at $5.19 million, up 44.5% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $3.59 million in FY2024 (+59.7%), $2.25 million in FY2023 (-3.4%), $2.33 million in FY2022 (-8.5%) and $2.54 million in FY2021 (+5.2%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q1 2018.
- Compared with a year earlier, Share-based Compensation has increased for 11 straight quarters, with growth averaging 66.6% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2026 (growth of 136.4%); the worst was Q2 2022 (a decline of 30.2%).
- Per Business Quant data, TRVI's Share-based Compensation in the three quarters before Q2 2026 was $2.19 million (Q1 2026), $1.35 million (Q4 2025) and $1.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Trevi Therapeutics | 2.05 Bn | 2.05 Bn | - | 3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.27 Mn |
| Mar 31, 2026 | 2.19 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 917,000.00 |
| Sep 30, 2024 | 822,000.00 |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 723,000.00 |
| Dec 31, 2023 | 534,000.00 |
| Sep 30, 2023 | 530,000.00 |
| Jun 30, 2023 | 530,000.00 |
| Mar 31, 2023 | 578,000.00 |
| Dec 31, 2022 | 501,000.00 |
| Sep 30, 2022 | 569,000.00 |
| Jun 30, 2022 | 520,000.00 |
| Mar 31, 2022 | 737,000.00 |
| Dec 31, 2021 | 540,000.00 |
| Sep 30, 2021 | 540,000.00 |
API Access
Trevi Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();